DCF — SOUTHEASTERN OHIO REG MED CTR
Enterprise Value: $-27.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-27.7M
Enterprise Value
$-11.4M
PV of Cash Flows
$-16.2M
PV of Terminal Value
$-26.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $97.1M | $-0.3M | -0.0% | $-4.4M | $-4.0M |
| Year 2 | $100.0M | $0.7M | 1.0% | $-3.5M | $-2.9M |
| Year 3 | $103.0M | $1.8M | 2.0% | $-2.6M | $-1.9M |
| Year 4 | $106.1M | $2.4M | 2.0% | $-2.1M | $-1.5M |
| Year 5 | $109.3M | $2.7M | 2.0% | $-1.9M | $-1.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-27.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$94.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.007686824001075518
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5